Zecotek Closes Second Tranche of Non-Brokered Private Placement Singapore, February 17, 2011 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has closed on the second and final tranche of the non-brokered private placement announced on January 18, 2011. […]
Zecotek Closes on First Tranche - C$4.7 Million
Zecotek Closes First Tranche of Non-Brokered Private Placement Singapore, February 9, 2011 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has closed on the first tranche of the non-brokered private placement announced on January 18, 2011. The Company […]
Non-Brokered Private Placement Increased to C$6.5 Million
Zecotek Increases Non-Brokered Private Placement to $6.5 Million Singapore, February 4, 2011 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has increase the previously announced non-brokered private placement by an additional $1 million. The Company is now offering […]
Non-Brokered Private Placement Increases to C$5.5 Million
Zecotek Increases Non-Brokered Private Placement to $5.5 Million Singapore, February 3, 2011 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has increase the previously announced non-brokered private placement by an additional $1.5 million. The Company is now offering […]
Non-Brokered Private Placement Increases to C$4 Million
Zecotek Increases Non-Brokered Private Placement to $4 Million Singapore, February 2, 2011 - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the Company has increase the previously announced non-brokered private placement by $3 million. The Company is offering 7,547,170 units of […]